Market Overview:

The Intermittent Catheters Market is experiencing robust expansion, driven by Increasing Prevalence of Urological Disorders, Rising Adoption of Appropriate Reimbursement Rules and Growing Geriatric Population. According to IMARC Group's latest research publication, "Intermittent Catheters Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global intermittent catheters market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers  and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Intermittent Catheters Industry:

• Increasing Prevalence of Urological Disorders

Urological disorders increasingly prevail and result in bladder dysfunction, for instance, urine retains, cystitis occurs, benign prostatic hyperplasia develops, urine is incontinent, and kidneys form stones, which is one of the major factors that contributes to driving the global urological catheters market. Patients increasingly suffer urinary dysfunction and require catheterization to drain and manage urine so they grow the market. As per UK's NHS England, 61% of the general male population and 34% of the general female population of UK have LUTS and urinary incontinence, respectively. The increasing prevalence of LUTS and urinary incontinence and their associated surgical interventions contributed to the increase in consumption of intermittent catheters throughout the UK, for ease of use post-operation.

• Rising Adoption of Appropriate Reimbursement Rules

Urinary retention is more common in a person with bladder neck obstruction, neurological disease or posterior urethral stricture. Depending on certain circumstances, intermittent catheterization may be covered by Medicare and Medicaid. Medicaid will cover, on a per month basis, up to 120 catheters. Medicare will cover 200. Straight, coude, hydrophilic, and antimicrobial catheters are all options available. The U.S. Centers for Medicare and Medicaid Services (CMS) issued guidelines for urinary incontinence care in nursing homes and offers online training for nursing facility staff to manage urinary incontinence. If people are more aware and reimburse properly, greater funding will likely direct itself toward researching and developing novel catheters. The catheters must have improved performance and be cost-effective.

• Growing Geriatric Population

Intermittent catheters are most commonly used for urinary retention, incontinence, pressure sores and cancer in older men and women. Health care workers use intermittent catheters to ease their burden of providing constant care for older patients. Intermittent catheters remain a valid option postoperatively or in patients with impaired mobility. The demand is expected to grow due to the aging population and the growing global burden of disease. The demand for intermittent catheters for bladder emptying in patients with chronic conditions is a major driver of growth in the intermittent catheters market.

Key Trends in the Intermittent Catheters Market

• Innovation in Catheter Design and Materials

Manufacturers are investing in new materials and coming up with newer products in order to improve the usability and safety of catheters. Pre-lubricated or hydrophilic catheters are being utilized more often as they are easier to use and result in less friction during self catheterization. The market growth can also be attributed to the growing focus on patient-centric devices and the introduction of advanced catheter products.

• Growing Focus on Home Healthcare

There is a focus on treatment in the home. Many people choose to self-catheterize at home, as this is more convenient and cheaper than alternative treatments. Growing prevalence of catheters is due to self-catheterization due to knowledge and awareness of urology. This improves quality of life and reduces need for hospital visits. Home-care has further increased demand for catheters and contributed to the growth of this market.

• Strategic Expansion in Emerging Markets

Key players who operate in the market focus on partnering and expanding in emerging markets to strengthen their market position. Companies focus on expanding their distribution networks within emerging markets. The emergence of planned acquisitions & collaborations to increase the market presence of companies is also expected to drive the market.

The Intermittent Catheters Market report provides a comprehensive overview of the industry. This analysis is essential for stakeholders aiming to navigate the complexities of the Intermittent Catheters Market and capitalize on emerging opportunities.

Leading Companies Operating in the Global Intermittent Catheters Industry:

• Adapta Medical, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Coloplast Corp
• Convatec Inc.
• Hollister Incorporated
• Medline Industries, LP
• Pennine Healthcare
• Teleflex Incorporated
• Wellspect HealthCare (Dentsply Sirona)

Intermittent Catheters Market Report Segmentation:

Breakup by Product:

• Uncoated Intermittent Catheter
• Coated Intermittent Catheter
• Antimicrobial
• Hydrophilic
• Others

Uncoated intermittent catheter dominates the market due to their continued success in enhancing patient comfort and infection control with cost-effective solutions.

Breakup by Indication:

• Urinary Incontinence
• Surgery (Major Surgery)
• Spinal Cord Injury
• Others

Urinary incontinence holds the largest share in the market as it affects over 423 million adults globally with growing awareness and diagnosis leading to increased adoption of intermittent catheters.

Breakup by Category:

• Male Length Catheter
• Kids Length Catheter
• Female Length Catheter

Female length catheter holds the maximum share in the market due to increasing prevalence of urinary disorders among women and catheters tailored to female anatomy for greater comfort.

Breakup by End User:

• Hospitals
• Medical Research Centers
• Ambulatory Surgical Centers

Hospitals hold the maximum share in the market as they handle higher volumes of patients requiring complex care with specialized medical staff and advanced facilities.

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market, accounting for the largest intermittent catheters market share driven by high prevalence of urological disorders, well-established healthcare infrastructure, and strong focus on home healthcare.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States:+1-201971-6302